StockData
Tevogen Inc. logo

Tevogen Inc. (TVGN) stock

TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$6.14+0.45 (+7.91%)

Close on Nov 18, 2026Market cap $39.98MP/E –Yield –

Tevogen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Tevogen

Tevogen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Tevogen figures

See a number that looks wrong?